1,452
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Repeated (S)-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota–brain axis

, , , , ORCID Icon, & show all
Article: 2310603 | Received 04 Jul 2023, Accepted 23 Jan 2024, Published online: 08 Feb 2024

References

  • Berryman C, Stanton TR, Jane Bowering K, Tabor A, McFarlane A, Lorimer Moseley G. Evidence for working memory deficits in chronic pain: a systematic review and meta-analysis. Pain. 2013;154(8):1181–20. doi:10.1016/j.pain.2013.03.002. PMID: 23707355.
  • Khera T, Rangasamy V. Cognition and pain: a review. Front Psychol. 2021;12:673962. doi:10.3389/fpsyg.2021.673962. PMID: 34093370.
  • Mazza S, Frot M, Rey AE. A comprehensive literature review of chronic pain and memory. Progress in neuro-psychopharmacology & biological psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt B):183–192. doi:10.1016/j.pnpbp.2017.08.006. PMID: 28797640.
  • Wang XM, Pan W, Xu N, Zhou ZQ, Zhang GF, Shen JC. Environmental enrichment improves long-term memory impairment and aberrant synaptic plasticity by BDNF/TrkB signaling in nerve-injured mice. Neurosci Lett. 2019;694:93–98. doi:10.1016/j.neulet.2018.11.049. PMID: 30496785.
  • Zhang GF, Zhou ZQ, Guo J, Gu HW, Su MZ, Yu BC, Zhou F, Han BY, Jia M, Ji MH. et al. Histone deacetylase 3 in hippocampus contributes to memory impairment after chronic constriction injury of sciatic nerve in mice. Pain. 2021;162(2):382–395. doi:10.1097/j.pain.0000000000002056. PMID: 32868749.
  • Dick BD, Rashiq S. Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg. 2007;104(5):1223–1229. doi:10.1213/01.ane.0000263280.49786.f5. PMID: 17456678.
  • Jefferson T, Kelly CJ, Martina M. Differential rearrangement of excitatory inputs to the medial prefrontal cortex in chronic pain models. Front Neural Circuits. 2021;15:791043. doi:10.3389/fncir.2021.791043. PMID: 35002635.
  • Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci. 2019;73(10):613–627. doi:10.1111/pcn.12902. PMID: 31215725.
  • Hashimoto K. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol. 2020;177:113935. doi:10.1016/j.bcp.2020.113935. PMID: 32224141.
  • Price RB, Spotts C, Panny B, Griffo A, Degutis M, Cruz N, Bell E, Do-Nguyen K, Wallace ML, Mathew SJ. et al. A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial. Am J Psychiatry. 2022;179(12):959–968. doi:10.1176/appi.ajp.20220216. PMID: 36128684.
  • Price RB, Kissel N, Baumeister A, Rohac R, Woody ML, Ballard ED, Zarate CA Jr., Deakin W, Abdallah CG, Feder A. et al. International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. Mol Psychiatr. 2022;27(12):5096–5112. doi:10.1038/s41380-022-01757-7. PMID: 36071111.
  • Wei Y, Chang L, Hashimoto K. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Mol Psychiatr. 2022;27(1):559–573. doi:10.1038/s41380-021-01121-1. PMID: 33963284.
  • Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856–864. doi:10.1001/archpsyc.63.8.856. PMID: 16894061.
  • Zhang K, Yao Y, Hashimoto K. Ketamine and its metabolites: potential as novel treatments for depression. Neuropharmacol. 2023;222:109305. doi:10.1016/j.neuropharm.2022.109305. PMID: 36354092.
  • Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV. et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. 2020;25(7):1592–1603. doi:10.1038/s41380-018-0256-5. PMID: 30283029.
  • Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, Lane R, Lim P, Duca AR, Hough D. et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiarty. 2019;76(9):893–903. doi:10.1001/jamapsychiatry.2019.1189. PMID: 31166571.
  • Jha MK, Williamson DJ, Magharehabed G, Turkoz I, Daly EJ, Trivedi MH. Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability. J Affect Disord. 2023;321:153–160. doi:10.1016/j.jad.2022.10.020. PMID: 36273682.
  • Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P, Wiegand F, Manji H. et al. Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol Psychiatry. 2016;80(6):424–431. doi:10.1016/j.biopsych.2015.10.018. PMID: 26707087.
  • Chen X, Wang M, Hu Y, Zhan Y, Zhou Y, Zheng W, Liu W, Wang C, Zhong X, Li H. et al. Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients. Eur Arch Psychiatry Clin Neurosci. 2021;271(3):431–438. doi:10.1007/s00406-020-01221-z. PMID: 33386430.
  • Hashimoto K. Arketamine for cognitive impairment in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci. 2023:1–13. doi:10.1007/s00406-023-01570-5. PMID: 36786865.
  • Gill H, Gill B, Rodrigues NB, Lipsitz O, Rosenblat JD, El-Halabi S, Nasri F, Mansur RB, Lee Y, McIntyre RS. The effects of ketamine on cognition in treatment-resistant depression: a systematic review and priority avenues for future research. Neurosci Biobehav Rev. 2021;120:78–85. doi:10.1016/j.neubiorev.2020.11.020. PMID: 33242561.
  • Wang X, Chang L, Wan X, Tan Y, Qu Y, Shan J, Yang Y, Ma L, Hashimoto K. (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis. Neurobiol Dis. 2022;165:105635. doi:10.1016/j.nbd.2022.105635. PMID: 35085752.
  • Hua H, Huang C, Liu H, Xu X, Xu X, Wu Z, Liu C, Wang Y, Yang C. Depression and antidepressant effects of ketamine and its metabolites: the pivotal role of gut microbiota. Neuropharmacol. 2022;220:109272. doi:10.1016/j.neuropharm.2022.109272. PMID: 36170927.
  • Ma L, Wang L, Chang L, Shan J, Qu Y, Wang X, Fujita Y, Hashimoto K. A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model. Neuropharmacol. 2022;219:109250. doi:10.1016/j.neuropharm.2022.109250. PMID: 36088985.
  • Yu H, Wang C, Lei Y, Li L, Wang H, Wang G, Xing L, Guan J, Song J, Wu Y. et al. Single-institution experience of venetoclax combined with azacitidine in newly diagnosed acute myeloid leukemia patients. Int Immunopharm-acol. 2023;127:111232. doi:10.1016/j.intimp.2023.111232. PMID: 38091830.
  • Wang T, Weng H, Zhou H, Yang Z, Tian Z, Xi B, Li Y. Esketamine alleviates postoperative depression-like behavior through anti-inflammatory actions in mouse prefrontal cortex. J Affect Disord. 2022;307:97–107. doi:10.1016/j.jad.2022.03.072. PMID: 35378150.
  • Wilkowska A, Szałach ŁP, Cubała WJ. Gut microbiota in depression: a focus on ketamine. Front Behav Neurosci. 2021;15:693362. doi:10.3389/fnbeh.2021.693362. PMID: 34248517.
  • Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastro Hepat. 2019;16(8):461–478. doi:10.1038/s41575-019-0157-3. PMID: 31123355.
  • Li Z, Sun T, He Z, Li Z, Zhang W, Wang J, Xiang H. Scfas ameliorate chronic postsurgical pain–related cognition dysfunction via the ACSS2-HDAC2 axis in rats. Mol Neurobiol. 2022;59(10):6211–6227. doi:10.1007/s12035-022-02971-8. PMID: 35902549.
  • Mitra S, Dash R, Nishan AA, Habiba SU, Moon IS. Brain modulation by the gut microbiota: from disease to therapy. J Adv Res. 2022;53:153–173. doi:10.1016/j.jare.2022.12.001. PMID: 36496175.
  • Medeiros GC, Gould TD, Prueitt WL, Nanavati J, Grunebaum MF, Farber NB, Singh B, Selvaraj S, Machado-Vieira R, Achtyes ED. et al. Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis. Mol Psychiatry. 2022;27(9):3658–3669. doi:10.1038/s41380-022-01652-1. PMID: 35760879.
  • Yang C, Shirayama Y, Zhang JC, Ren Q, Yao W, Ma M, Dong C, Hashimoto K. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry. 2015;5(9):e632. doi:10.1038/tp.2015.136. PMID: 26327690.
  • Yang C, Ren Q, Qu Y, Zhang JC, Ma M, Dong C, Hashimoto K. Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model. Biological Psychiatry. 2018;83(1):18–28. doi:10.1016/j.biopsych.2017.05.016. PMID: 28651788.
  • Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87–107. doi:10.1016/0304-3959(88)90209-6. PMID: 2837713.
  • Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63. doi:10.1016/0165-0270(94)90144-9. PMID: 7990513.
  • Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for assessment of spatial working and reference memory in mice. Methods Mol Biol. 2019;1916:105–111. doi:10.1007/978-1-4939-8994-2_10. PMID: 30535688.
  • Zhang Y, Huang R, Cheng M, Wang L, Chao J, Li J, Zheng P, Xie P, Zhang Z, Yao H. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2. Microbiome. 2019;7(1):116. doi:10.1186/s40168-019-0733-3. PMID: 31439031.
  • Walker JM. Isoelectric focusing of proteins in ultra-thin polyacrylamide gels. Methods Mol Biol. 1994;32:59–65. doi:10.1385/0-89603-268-x:59. PMID: 7951749.
  • Park OJ, Ha YE, Sim JR, Lee D, Lee EH, Kim SY, Yun CH, Han SH. Butyrate potentiates enterococcus faecalis lipoteichoic acid-induced inflammasome activation via histone deacetylase inhibition. Cell Death Discovery. 2023;9(1):107. doi:10.1038/s41420-023-01404-2. PMID: 36977666.
  • Qiu LL, Pan W, Luo D, Zhang GF, Zhou ZQ, Sun XY, Yang JJ, Ji MH. Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca(2+)/calpain might contribute to postoperative cognitive dysfunction in aging mice. J Neuroinflammation. 2020;17(1):23. doi:10.1186/s12974-019-1695-x. PMID: 31948437.
  • Xia SH, Hu SW, Ge DG, Liu D, Wang D, Zhang S, Zhang Q, Yuan L, Li YQ, Yang JX. et al. Chronic pain impairs memory formation via disruption of neurogenesis mediated by Mesohippocampal brain-derived neurotrophic factor signaling. Biol Psychiatry. 2020;88(8):597–610. doi:10.1016/j.biopsych.2020.02.013. PMID: 32307038.
  • Liu JZ, Zhang LM, Zhang DX, Song RX, Lv JM, Wang LY, Jia SY, Shan YD, Shao JJ, Zhang W. NLRP3 in the GABAergic neuron induces cognitive impairments in a mouse model of hemorrhage shock and resuscitation. J Psychiatr Res. 2023;159:213–223. doi:10.1016/j.jpsychires.2023.01.034. PMID: 36739849.
  • Li Y, Wu ZY, Zheng WC, Wang JX, Yue X, Song RX, Gao JG. Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes/TANK-binding kinase 1 signaling pathway in aged rats. Brain Res Bull. 2022;187:169–180. doi:10.1016/j.brainresbull.2022.07.004. PMID: 35839904.
  • Dimitrov EL, Tsuda MC, Cameron HA, Usdin TB. Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity. J Neurosci. 2014;34(37):12304–12312. doi:10.1523/JNEUROSCI.0312-14.2014. PMID: 25209272.
  • Humo M, Ayazgök B, Becker LJ, Waltisperger E, Rantamäki T, Yalcin I. Ketamine induces rapid and sustained antidepressant-like effects in chronic pain ind-uced depression: role of MAPK signaling pathway. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109898. doi:10.1016/j.pnpbp.2020.109898. PMID: 32109506.
  • Velzen MV, Dahan JDC, van Dorp ELA, Mogil JS, Hooijmans CR, Dahan A, van Dorp ELA. Efficacy of ketamine in relieving neuropathic pain: a systematic review and meta-analysis of animal stu-dies. Pain. 2021;162(9):2320–2330. doi:10.1097/j.pain.0000000000002231. PMID: 33790195.
  • Chakrabarti A, Geurts L, Hoyles L, Iozzo P, Kraneveld AD, La Fata G, Miani M, Patterson E, Pot B, Shortt C. et al. The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci. 2022;79(2):80. doi:10.1007/s00018-021-04060-w. PMID: 35044528.
  • Kim H, Kim S, Park SJ, Park G, Shin H, Park MS, Kim J. Administration of bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI improves cognitive and memory function in the mouse model of Alzheimer’s disease. Front Aging Neurosci. 2021;13:709091. doi:10.3389/fnagi.2021.709091. PMID: 34421576.
  • Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, Chen LJ, Li MD, Ning YP. Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. J Affect Disord. 2019;246:241–247. doi:10.1016/j.jad.2018.12.005. PMID: 30590286.
  • Wang Y, Jiang R, Wu Z, Zhou L, Xu J, Huang C, Yang L, Zhu B, Yan E, Liu C. et al. Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression. Pharmacol Biochem Behav. 2021;207:173226. doi:10.1016/j.pbb.2021.173226. PMID: 34217782.
  • Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041. PMID: 27259147.
  • Doifode T, Giridharan VV, Generoso JS, Bhatti G, Collodel A, Schulz PE, Forlenza OV, Barichello T. The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology. Pharmacol Res. 2021;164:105314. doi:10.1016/j.phrs.2020.105314. PMID: 33246175.
  • Kukkar A, Singh N, Jaggi AS. Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats. J Formosan Med Associat = Taiwan Yi Zhi. 2014;113(12):921–928. doi:10.1016/j.jfma.2013.05.013. PMID: 23870713.
  • Khan A, Khan S, Kim YS. Insight into pain modulation: nociceptors sensitization and therapeutic targets. Curr Drug Targets. 2019;20(7):775–788. doi:10.2174/1389450120666190131114244. PMID: 30706780.
  • Guo W, Li Z, Fu X, Zhou W, Ren J, Wu Y. Effect of staphylococcus aureus contamination on the microbial diversity and metabolites in wholewheat sourdough. Foods (Basel, Switzerland). 2022;11(13):1960. doi:10.3390/foods11131960. PMID: 35804775.
  • Huang HS, Lin YE, Panyod S, Chen RA, Lin YC, Chai LMX, Hsu CC, Wu WK, Lu KH, Huang YJ. et al. Anti-depressive-like and cognitive impairment alleviation effects of gastrodia elata Blume water extract is related to gut microbiome remodeling in ApoE−/− mice exposed to unpredictable chronic mild stress. J Ethnopharmacol. 2023;302(Pt B):115872. doi:10.1016/j.jep.2022.115872. PMID: 36343797.
  • Liu L, Wang H, Zhang H, Chen X, Zhang Y, Wu J, Zhao L, Wang D, Pu J, Ji P. et al. Toward a deeper understanding of gut microbiome in depression: the promise of clinical applicability. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2022;9(35):e2203707. doi:10.1002/advs.202203707. PMID: 36285702.
  • O’Hagan C, Li JV, Marchesi JR, Plummer S, Garaiova I, Good MA. Long-term multi-species lactobacillus and bifidobacterium dietary supplement enhances memory and changes regional brain metabolites in middle-aged rats. Neurobiol Learn Mem. 2017;144:36–47. doi:10.1016/j.nlm.2017.05.015. PMID: 28602659.
  • Xiao Y, Zhao J, Zhang H, Zhai Q, Chen W. Colonized Niche, evolution and function signatures of bifidobacterium pseudolongum within bifidobacterial genus. Foods (Basel, Switzerland). 2021;10(10):2284. doi:10.3390/foods10102284. PMID: 34681333.
  • Yang X, Yu D, Xue L, Li H, Du J. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B. 2020;10(3):475–487. doi:10.1016/j.apsb.2019.07.001. PMID: 32140393.
  • Yang C, Fujita Y, Ren Q, Ma M, Dong C, Hashimoto K. Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice. Sci Rep. 2017;7(1):45942. doi:10.1038/srep45942. PMID: 28368029.